Page last updated: 2024-10-30

loperamide and Encephalopathy, Toxic

loperamide has been researched along with Encephalopathy, Toxic in 1 studies

Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.

Research Excerpts

ExcerptRelevanceReference
"Loperamide (LOP) is a peripherally acting opioid receptor agonist used for the management of chronic diarrhea through the reduction of gut motility."2.71Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers. ( Heming, T; Hoelscher, D; Johnson, P; Kavanaugh, K; Legg, D; MacGregor, T; McCallister, S; Mukwaya, G; Sabo, JP, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mukwaya, G1
MacGregor, T1
Hoelscher, D1
Heming, T1
Legg, D1
Kavanaugh, K1
Johnson, P1
Sabo, JP1
McCallister, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Open-label, Randomized, Fasting, Two-period, Single-dose, Crossover Study to Assess Bioequivalence Between a Combination Caplet With Loperamide Hydrochloride and Simethicone (Janssen-Cilag, France), and ImodiumĀ® Express Tablets-lyophilizate (Janssen-Ci[NCT04186936]Phase 148 participants (Actual)Interventional2019-12-05Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for loperamide and Encephalopathy, Toxic

ArticleYear
Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12

    Topics: Adult; Caco-2 Cells; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactio

2005